Cuneyt Unsal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cuneyt Unsal has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Birol Topcu
Department of Biostatistics, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
2 shared publicationsMustafa Oran
Department of Internal Medicine, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
2 shared publicationsOmer Yanartas
Department of Psychiatry, The Ministry of Health of Turkey, Marmara University Hospital Pendik Training and Research Hospital, Istanbul, Turkey
2 shared publicationsAytul Gursu Hariri
1 shared publication- Aytül Gürsu Hariri
Erenköy Ruh ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi, İstanbul-Türkiye
1 shared publication Cevat Aktas
Department of Histology and Embryology, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
1 shared publication
Latest Publications
- 14 November 2013
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 32 (4) , 730-740
Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats
The goal of this study was to examine the neuroprotective effect of ebselen against intracerebroventricular streptozotocin (ICV-STZ)-induced oxidative stress and neuronal apoptosis in rat brain. A total of 30 adult male Sprague-Dawley rats were randomly divided into 3 groups of 10 animals each: control, ICV-STZ, and ICV-STZ treated with ebselen. The ICV-STZ group rats were injected bilaterally with ICV-STZ (3 mg/kg) on days 1 and 3, and ebselen (10 mg/kg/day) was administered for 14 days starting from 1st day of ICV-STZ injection to day 14. Rats were killed at the end of the study and brain tissues were removed for biochemical and histopathological investigation. Our results demonstrated, for the first time, the neuroprotective effect of ebselen on Alzheimer’s disease (AD) model in rats. Our present study, in ICV-STZ group, showed significant increase in tissue malondialdehyde levels and significant decrease in enzymatic antioxidants superoxide dismutase and glutathione peroxidase in the frontal cortex tissue. The histopathological studies in the brain of rats also supported that ebselen markedly reduced the ICV-STZ-induced histopathological changes and well preserved the normal histological architecture of the frontal cortex tissue. The number of apoptotic neurons was increased in frontal cortex tissue after ICV-STZ administration. Treatment of ebselen markedly reduced the number of degenerating apoptotic neurons. The study demonstrates the effectiveness of ebselen, as a powerful antioxidant, in preventing the oxidative damage and morphological changes caused by ICV-STZ in rats. Thus, ebselen may have a therapeutic value for the treatment of AD.
- 14 November 2013
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 32 (4) , 730-740
Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats
The goal of this study was to examine the neuroprotective effect of ebselen against intracerebroventricular streptozotocin (ICV-STZ)-induced oxidative stress and neuronal apoptosis in rat brain. A total of 30 adult male Sprague-Dawley rats were randomly divided into 3 groups of 10 animals each: control, ICV-STZ, and ICV-STZ treated with ebselen. The ICV-STZ group rats were injected bilaterally with ICV-STZ (3 mg/kg) on days 1 and 3, and ebselen (10 mg/kg/day) was administered for 14 days starting from 1st day of ICV-STZ injection to day 14. Rats were killed at the end of the study and brain tissues were removed for biochemical and histopathological investigation. Our results demonstrated, for the first time, the neuroprotective effect of ebselen on Alzheimer’s disease (AD) model in rats. Our present study, in ICV-STZ group, showed significant increase in tissue malondialdehyde levels and significant decrease in enzymatic antioxidants superoxide dismutase and glutathione peroxidase in the frontal cortex tissue. The histopathological studies in the brain of rats also supported that ebselen markedly reduced the ICV-STZ-induced histopathological changes and well preserved the normal histological architecture of the frontal cortex tissue. The number of apoptotic neurons was increased in frontal cortex tissue after ICV-STZ administration. Treatment of ebselen markedly reduced the number of degenerating apoptotic neurons. The study demonstrates the effectiveness of ebselen, as a powerful antioxidant, in preventing the oxidative damage and morphological changes caused by ICV-STZ in rats. Thus, ebselen may have a therapeutic value for the treatment of AD.
- Open Access
- 1 October 2013
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 9, 1531-1537
Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia
Background: Patients with schizophrenia have a higher risk for cardiovascular diseases, which is associated with early mortality compared with the nonschizophrenic population. Early diagnosis of cardiovascular diseases in asymptomatic periods in patients with schizophrenia would enhance their quality of life and reduce mortality. Echocardiography, carotid ultrasonography, and ankle brachial index (ABI) measurement are known to be beneficial methods of detecting subclinical cardiovascular diseases and of risk stratification. The present study investigated carotid intima media thickness (CIMT) and ABI and echocardiographic parameters measured via conventional and tissue Doppler echocardiography in patients with schizophrenia in comparison with a control group. Methods: The present case-control study included 116 patients with schizophrenia and 88 healthy patients. Participants with any current comorbid psychiatric disorder, current or lifetime neurological and medical problems, current coronary artery disease, diabetes, hypertension, hypothyroidism, or hyperthyroidism or who were using antihypertensives, antidiabetic agents, or antiobesity drugs were excluded. High-resolution B-mode ultrasound images were used to measure CIMT. Conventional and tissue Doppler measurements were performed according to the recommendations of the American Society of Echocardiography. Results: Low ABI, mitral ratio of the early (E) to late (A) ventricular filling velocities, septal E´, septal S´, lateral E´, lateral S´, septal E´/septal A´, lateral E´/lateral A´, and high septal A´, mitral E/septal E´, mitral E/lateral E´, and CIMT values were observed in the schizophrenia group compared with the control group. Conclusion: Doppler parameters supported the hypothesis that patients with schizophrenia are at high risk for cardiovascular diseases.
- 1 October 2013
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 9, 1531-1537
Open AccessDetection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia
Background: Patients with schizophrenia have a higher risk for cardiovascular diseases, which is associated with early mortality compared with the nonschizophrenic population. Early diagnosis of cardiovascular diseases in asymptomatic periods in patients with schizophrenia would enhance their quality of life and reduce mortality. Echocardiography, carotid ultrasonography, and ankle brachial index (ABI) measurement are known to be beneficial methods of detecting subclinical cardiovascular diseases and of risk stratification. The present study investigated carotid intima media thickness (CIMT) and ABI and echocardiographic parameters measured via conventional and tissue Doppler echocardiography in patients with schizophrenia in comparison with a control group. Methods: The present case-control study included 116 patients with schizophrenia and 88 healthy patients. Participants with any current comorbid psychiatric disorder, current or lifetime neurological and medical problems, current coronary artery disease, diabetes, hypertension, hypothyroidism, or hyperthyroidism or who were using antihypertensives, antidiabetic agents, or antiobesity drugs were excluded. High-resolution B-mode ultrasound images were used to measure CIMT. Conventional and tissue Doppler measurements were performed according to the recommendations of the American Society of Echocardiography. Results: Low ABI, mitral ratio of the early (E) to late (A) ventricular filling velocities, septal E´, septal S´, lateral E´, lateral S´, septal E´/septal A´, lateral E´/lateral A´, and high septal A´, mitral E/septal E´, mitral E/lateral E´, and CIMT values were observed in the schizophrenia group compared with the control group. Conclusion: Doppler parameters supported the hypothesis that patients with schizophrenia are at high risk for cardiovascular diseases.
- 1 August 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 139 (3) , 302-305
Low plasma adiponectin levels in panic disorder
- 1 August 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 139 (3) , 302-305
Low plasma adiponectin levels in panic disorder
- Open Access
- 1 January 2010
- Published by Taylor & Francis in Klinik Psikofarmakoloji Bülteni / Bulletin of Clinical Psychopharmacology
- Vol. 20 (1) , 94-97
Behçet Hastalığı ve Geç Başlayan Hızlı Döngülü İki Uçlu Duygudurum Bozukluğu: Bir Olgu Sunumu
ÖZET Behçet hastalığı (BH) tanısı ile 16 yıldır izlenen 48 yaşındaki kadın hasta 41 yaşında iken iki uçlu duygudurum bozukluğu (İUDB) tanısı almıştı. Hasta son karma atağı nedeniyle hastanemizde yatarak tedavi görürken, her iki hastalığının birbirlerine karşılıklı etkisi incelendi. Bilindiği gibi, Behçet hastalığı ile duygudurum bozukluklarının karşılıklı etkileşimi ve hastanın yaşam kalitesini değiştirmesi söz konusu olabilmektedir. Bu hastada, BH'dan yaklaşık 9 yıl sonra başlayan İUDB'nun son 2 yıldır hızlı döngülü hale dönüştüğü, buna karşılık BH'nın duygudurum bozukluğu başlamasından sonra gittikçe düzelerek nerdeyse tam olarak iyileşme gösterdiği belirlenmiştir. Duygudurum ataklarının hızlı hale dönüşmesinin hastanın yaşamını güçleştirdiği ve tedaviye uyumunu bozduğu gözlemlendi. Yapılan literatür incelemesinde BH ve İUDB birlikteliği ile ilgili az sayıda yayın bulunduğu görülmüştür. Bu yazıda, nadir görülen bu birlikteliğin literatürdeki benzerleriyle karşılaştırılması ve olası nedenleri tartışılmıştır.
- 1 January 2010
- Published by Taylor & Francis in Klinik Psikofarmakoloji Bülteni / Bulletin of Clinical Psychopharmacology
- Vol. 20 (1) , 94-97
Open AccessBehçet Hastalığı ve Geç Başlayan Hızlı Döngülü İki Uçlu Duygudurum Bozukluğu: Bir Olgu Sunumu
ÖZET Behçet hastalığı (BH) tanısı ile 16 yıldır izlenen 48 yaşındaki kadın hasta 41 yaşında iken iki uçlu duygudurum bozukluğu (İUDB) tanısı almıştı. Hasta son karma atağı nedeniyle hastanemizde yatarak tedavi görürken, her iki hastalığının birbirlerine karşılıklı etkisi incelendi. Bilindiği gibi, Behçet hastalığı ile duygudurum bozukluklarının karşılıklı etkileşimi ve hastanın yaşam kalitesini değiştirmesi söz konusu olabilmektedir. Bu hastada, BH'dan yaklaşık 9 yıl sonra başlayan İUDB'nun son 2 yıldır hızlı döngülü hale dönüştüğü, buna karşılık BH'nın duygudurum bozukluğu başlamasından sonra gittikçe düzelerek nerdeyse tam olarak iyileşme gösterdiği belirlenmiştir. Duygudurum ataklarının hızlı hale dönüşmesinin hastanın yaşamını güçleştirdiği ve tedaviye uyumunu bozduğu gözlemlendi. Yapılan literatür incelemesinde BH ve İUDB birlikteliği ile ilgili az sayıda yayın bulunduğu görülmüştür. Bu yazıda, nadir görülen bu birlikteliğin literatürdeki benzerleriyle karşılaştırılması ve olası nedenleri tartışılmıştır.